一种用于预测糖尿病患者动脉动脉样硬化风险的新型名图
Jing Liu1, Shoukun Dou2, Yuan Zhang1
1Centre of Health Management, Shenzhen Hospital of Southern Medical University, No. 1333 Xinhu Road, Baoan District, Shenzhen, 518101, China.
BMC cardiovascular disorders
|August 19, 2025
概括
一种新的诺莫图谱预测2型糖尿病患者的动脉动脉样硬化. 它识别了年龄,血压和胆固醇等关键风险因素,有助于早期干预,改善心血管健康.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 医疗信息学 医疗信息学
背景情况:
- 心血管疾病是全球领先的健康问题.
- 动脉样硬化显著导致心血管疾病,特别是在2型糖尿病患者中.
- 在这个人群中缺乏有效的动脉动脉样硬化风险分层工具.
研究的目的:
- 开发和验证一个预测性诺米克图用于动脉样硬化.
- 在2型糖尿病患者中确定动脉动脉样硬化的独立风险因素.
- 为早期干预和个性化管理提供一个工具.
主要方法:
- 这是一项对1258名2型糖尿病患者的回顾性队列研究.
- 数据分为培训 (n=616),内部验证 (n=264) 和外部验证 (n=378) 的数据集.
- 用于风险因素识别的LASSO和多变量逻辑回归;使用ROC,校准和决策曲线分析开发和验证nomogram.
主要成果:
- 确定了年龄,吸烟,饮酒,静脉压,脂蛋白 (a),非高密度脂蛋白胆固醇和肌素作为独立的危险因素.
- 诺莫格拉姆显示出良好的区分 (AUC:0.791,0.725,0.721用于培训,内部,外部验证).
- 强大的校准和确认的临床实用性,特别是对于超过15%的门概率.
结论:
- 开发的诺米图是预测2型糖尿病中动脉样硬化风险的强有力的工具.
- 促进早期检测和个性化管理策略.
- 改善了糖尿病患者心血管风险分层的临床实践.
相关概念视频
01:30Coronary Artery Disease I: Introduction
55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
38
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38
01:23Atherosclerosis IV: Nursing Management
50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
34
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
34
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
119
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33